Short Interest in Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) Decreases By 62.6%

Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) was the target of a significant decrease in short interest in the month of January. As of January 15th, there was short interest totalling 10,400 shares, a decrease of 62.6% from the December 31st total of 27,800 shares. Based on an average daily trading volume, of 273,300 shares, the short-interest ratio is presently 0.0 days.

Biodexa Pharmaceuticals Trading Down 1.5 %

BDRX stock traded down $0.07 during midday trading on Tuesday, hitting $4.25. 9,430 shares of the company’s stock were exchanged, compared to its average volume of 14,978. Biodexa Pharmaceuticals has a one year low of $3.50 and a one year high of $74.00. The stock’s fifty day moving average is $4.48.

Biodexa Pharmaceuticals Company Profile

Biodexa Pharmaceuticals Plc, a clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of Type 1 diabetes and rare/orphan cancers of the brain. Its lead product candidate Tolimidone, a selective activator of the lyn kinase enzyme, currently under Phase II studies for the treatment of Type 1 diabetes.